Prosecution Insights
Last updated: May 29, 2026

Examiner: LIPPERT, JOHN WILLIAM

Tech Center 1600 • Art Units: 1615 1621 1627

This examiner grants 56% of resolved cases

Performance Statistics

55.7%
Allow Rate
-4.3% vs TC avg
202
Total Applications
+42.6%
Interview Lift
1228
Avg Prosecution Days
Based on 149 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
1.1%
§102 Novelty
89.0%
§103 Obviousness
2.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18042390 FUNCTIONAL IONIZABLE PHOSPHOLIPIDS Final Rejection The Board of Regents of The University of Texas System
17772709 OXYGEN-GENERATING WOUNDING HEALING DRESSING Non-Final OA University of Florida Research Foundation, Inc.
18289661 Lipid Nanoparticle-Mediated mRNA Delivery to the Pancreas Non-Final OA Carnegie Mellon University
18637039 LONG-WEAR COMPOSITIONS Non-Final OA L'OREAL
18258911 COSMETIC COMPOSITION COMPRISING A COPOLYMER BASED ON ACETOACETATE FUNCTIONS Non-Final OA L'OREAL
18547550 PESTICIDAL FORMULATIONS Final Rejection SYNGENTA CROP PROTECTION AG
17996618 LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18197957 POLYMER NANOPARTICLE, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD FOR INTRACELLULAR DELIVERY OF A CARGO Final Rejection UNIVERSITY OF MASSACHUSETTS
18584761 COMPOSITION INCLUDING A METAL-ORGANIC FRAMEWORK (MOF) NANOPARTICLE FOR ORAL PROTEIN ADMINISTRATION Non-Final OA WUHAN UNIVERSITY
18037684 MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME Non-Final OA University of Virginia Patent Foundation
18710253 NON-AQUEOUS DENTIFRICE COMPOSITION Non-Final OA HALEON UK IP LIMITED
18179191 DISINFECTING FORMULATIONS WITH CARVACROL Non-Final OA THE CLOROX COMPANY
17614842 MODIFIED RELEASE FORMULATION OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF TREATMENT Final Rejection DENALI THERAPEUTICS INC.
18553658 PESTICIDAL MIXTURES Non-Final OA ADAMA MAKHTESHIM LTD.
18624168 PREPARATION METHOD FOR SILICON DIOXIDE, AND TOOTHPASTE Non-Final OA Jinsanjiang (Zhaoqing) Silicon Material Co., LTD.
18188154 PHOSPHOLIPID PRESENTING PARTICLES FOR CELL TARGETING IN THERAPY AND DIAGNOSTICS Non-Final OA UNIVERSITY OF SOUTH CAROLINA
18693229 COSMETIC PREPARATION CONTAINING LIME GLASS BEADS WITH HIGH SPECIFIC WEIGHT Non-Final OA BEIERSDORF AG
18273581 THERMALLY STABLE, MINERAL OIL-FREE W/O EMULSION Non-Final OA BEIERSDORF AG
18688910 Methods and Compositions for Growing Plants Non-Final OA GreenTech Ventures, Inc.
18688519 COMPOSITIONS AND METHODS FOR TARGETED DEGRADATION OF PROTEINS IN A PLANT CELL Non-Final OA Oerth Bio LLC
18686065 LYOPHILISED FORMULATIONS OF mRNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES Non-Final OA GENNOVA BIOPHARMACEUTICALS LTD.
18684222 ANHYDROUS TOPICAL DELIVERY SYSTEM FOR LIPID, AQUEOUS, AND ALCOHOL SOLUBILIZED ACTIVES Non-Final OA Morse Laboratories L.P.
18573401 SONOSENSITIVE COMPOSITION Non-Final OA Institut National de la Santé et de la Recherche Médicale
18569188 METHODS OF CREATING A SLURRY USING LIPOSOME EMULSIONS Non-Final OA Brixton Biosciences, Inc.
17919415 INJECTABLE OIL-BASED PHARMACEUTICAL COMPOSITION Final Rejection NANEXA AB
18564780 Method for Producing an Ionizable Lipid Non-Final OA NanoVation Therapeutics Inc.
18290028 SYNERGISTIC AGROCHEMICAL OIL DISPERSION FORMULATION Final Rejection RAJDHANI PETROCHEMICALS PRIVATE LIMITED
18258742 Method For Producing Patient-Optimised Dosage Forms Non-Final OA DiHeSys Digital Health Systems GmbH
18549702 Nanofiber- and Nanowhisker-Based Transfection Platforms for Bulk Electroporation Non-Final OA Nanofiber Solutions, LLC
18214068 Method for Preparing an Aqueous Nanocrystalline Suspension Containing Nanocrystals of Pharmaceutically Active Ingredient and a Combination of Stabilizers, Aqueous Nanocrystalline Suspension and Methods of Use Thereof Final Rejection Vysoka skola chemicko-technologicka v Praze

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month